Bosentas 125mg Tablet is a prescription oral medication used primarily for the management of pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries of the lungs. PAH can lead to shortness of breath, fatigue, and right-sided heart failure if left untreated. Bosentan belongs to the class of drugs known as endothelin receptor antagonists (ERAs). It works by blocking endothelin, a substance in the body that causes blood vessels to constrict, thereby reducing pulmonary vascular resistance and improving blood flow to the lungs.

By lowering pulmonary artery pressure, Bosentas 125mg Tablet helps patients enhance exercise capacity, reduce symptoms, and improve overall quality of life. This medication is often prescribed as part of a comprehensive PAH management plan, which may include lifestyle modifications, supplemental oxygen, and other therapies. It is particularly beneficial for adults with WHO functional class II–III PAH, either idiopathic, heritable, or associated with connective tissue disease.

Before starting Bosentan, patients undergo liver function tests, blood counts, and pregnancy screening, as the drug may have significant interactions and side effects. Regular monitoring during therapy ensures safe and effective use, allowing healthcare providers to adjust the dosage if necessary.